Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cost-Effectiveness of New Therapies for Multiple Sclerosis In Spain.
Positive association of vitamin d receptor gene variations with multiple sclerosis in South East Iranian population.
Measurement and maintenance of reserve in multiple sclerosis.
Youth and environmental enrichment generate serum exosomes containing miR-219 that promote CNS myelination.
Diffusion Weighted MRI Characterization of White Matter Injury Produced by Axon-sparing Demyelination and Severe Contusion Spinal Cord Injury in Rats.
Multiple sclerosis and amyotrophic lateral sclerosis: is there a link?
Anti-neuropathic effects of Rosmarinus officinalis L. terpenoid fraction: relevance of nicotinic receptors.
Cellulose/soy protein composite-based nerve guidance conduits with designed microstructure for peripheral nerve regeneration.
Dendritic cells as therapeutic targets in neuroinflammation.
Budget Impact Analysis of Delayed-Release Dimethylfumarate In The Treatment of Relapsing-Remitting Multiple Sclerosis In Italy.
Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders.
Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
Pediatric multiple sclerosis.
Acute demyelinating lesions with restricted diffusion in multiple sclerosis.
CNS myelin structural modification induced in vitro by phospholipases A2.
Feasibility study design and methods for Project GEMS: Guidelines for Exercise in Multiple Sclerosis.
A systematic review of stress-management interventions for multiple sclerosis patients.
Sex bias in CNS autoimmune disease mediated by androgen control of autoimmune regulator.
Peloruside A: a lead non-taxoid-site microtubule-stabilizing agent with potential activity against cancer, neurodegeneration, and autoimmune disease.
What do we know about brain contrast enhancement patterns in neuromyelitis optica?
Atypical presentation of Charcot-Marie-Tooth disease 1A: A case report.
Molecular dynamics and intracellular signaling of the TNF-R1 with the R92Q mutation.
Patterns Of Use Of Tests To Monitor Disease Activity Among Patients Currently Treated For Relapsing Remitting Multiple Sclerosis (Rrms) In Europe.
Variations in and predictors of the occurrence of depressive symptoms and mood symptoms in multiple sclerosis: a longitudinal two-year study.
Environmental factors and their interactions with risk genotypes in MS susceptibility.
Pages
« first
‹ previous
…
673
674
675
676
677
678
679
680
681
…
next ›
last »